Back
Citi Trends Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
44
CTRN
Citi Trends
Last Price:
19.05
Seasonality Move:
5.32%
Buy
100
RYTM
Rhythm Pharmaceuticals
Last Price:
67.31
Seasonality Move:
9.98%
Sell
44
Citi Trends (CTRN)
is a Sell
Is Citi Trends a Buy, Sell or Hold?
- The current Citi Trends [CTRN] share price is $19.07. The Score for CTRN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- CTRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
100
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $67.33. The Score for RYTM is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
CTRN Stock Price Chart
What is Citi Trends's stock price today?
-
The Citi Trends share price today is $19.07
The current trend is moderately bearish and CTRN is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $67.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
CTRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 49.7 | Sell |
Chaikin Money Flow: | -15408 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.01 - 19.77) | Sell |
Bollinger Bands (100): | (16.12 - 20.24) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.14 | Buy |
Relative Strength Index (14 RSI): | 81.29 | Buy |
Chaikin Money Flow: | 966983 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.36 - 56.78) | Buy |
Bollinger Bands (100): | (43.87 - 52.87) | Buy |
CTRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.24 | Sell |
20-day SMA: | 19.44 | Sell |
50-day SMA: | 17.99 | Buy |
200-day SMA: | 22.03 | Sell |
8-day EMA: | 19.33 | Sell |
20-day EMA: | 19.22 | Sell |
50-day EMA: | 18.68 | Buy |
200-day EMA: | 20.56 | Sell |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.18 | Buy |
20-day SMA: | 52.43 | Buy |
50-day SMA: | 50.91 | Buy |
200-day SMA: | 45.07 | Buy |
8-day EMA: | 58.59 | Buy |
20-day EMA: | 54.14 | Buy |
50-day EMA: | 51.2 | Buy |
200-day EMA: | 44.61 | Buy |
Citi Trends Earnings Growth & CTRN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.13 per share, and a decrease next year of $2.30 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
Citi Trends Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |